Predicting kidney stone recurrence and complications using precision medicine
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks for better ways to predict when kidney stones may come back and what complications might happen. It may help doctors personalize follow-up and prevention plans based on information collected from you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have had at least one kidney stone pain episode (renal colic) before joining
- You can understand the study and agree to participate by signing consent
- You are covered by social security (have the required health coverage)
- You are not currently pregnant or breastfeeding
- You are not in an emergency situation at the time of enrollment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a medication called empagliflozin, combined with personalized diet advice, can help prevent kidney stones from coming back. It may be an option if you've had two or more kidney stone events in the last 10 years and your stones were mostly calcium-based.
This study looks at whether having a change in the CYP24A1 gene raises the risk of kidney stones. It involves collecting urine for 24 hours and a day at the hospital. The results may help understand why some people get kidney stones and guide future care.
This study looks at a blood test done before percutaneous nephrolithotomy (PCNL), a procedure to remove kidney stones. The goal is to see whether results can predict who is more likely to develop infections or strong whole-body inflammation after surgery.
This study looks at genes in people who form calcium phosphate kidney stones. It may help doctors understand why some people make this type of stone.
This study looks at how the body reacts to calcium-based kidney stones. It compares people who have had a calcium-based kidney stone with healthy volunteers to understand inflammation better.
This study tests a treatment to prevent kidney stones from coming back after they are removed with a procedure called PCNL. The treatment uses a solution called dioxidine to help stop infection-related stones from forming again.
Hear when a new Kidney Stone trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.